AAAAAA

   
Results: 1-8 |
Results: 8
TARGETED GENE-THERAPY FOR CANCER - HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE-MEDIATED CELL-KILLING LEADS TO ANTITUMOR IMMUNITY THAT CAN BEAUGMENTED BY COEXPRESSION OF CYTOKINES IN THE TUMOR-CELLS
Authors: VILE RG DIAZ RM CASTLEDEN S CHONG H
Citation: Rg. Vile et al., TARGETED GENE-THERAPY FOR CANCER - HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE-MEDIATED CELL-KILLING LEADS TO ANTITUMOR IMMUNITY THAT CAN BEAUGMENTED BY COEXPRESSION OF CYTOKINES IN THE TUMOR-CELLS, Biochemical Society transactions, 25(2), 1997, pp. 717-722
GENERATION OF AN ANTITUMOR IMMUNE-RESPONSE IN A NONIMMUNOGENIC TUMOR - HSVTK KILLING IN-VIVO STIMULATES A MONONUCLEAR CELL INFILTRATE AND ATH1-LIKE PROFILE OF INTRATUMORAL CYTOKINE EXPRESSION
Authors: VILE RG CASTLEDEN S MARSHALL J CAMPLEJOHN R UPTON C CHONG H
Citation: Rg. Vile et al., GENERATION OF AN ANTITUMOR IMMUNE-RESPONSE IN A NONIMMUNOGENIC TUMOR - HSVTK KILLING IN-VIVO STIMULATES A MONONUCLEAR CELL INFILTRATE AND ATH1-LIKE PROFILE OF INTRATUMORAL CYTOKINE EXPRESSION, International journal of cancer, 71(2), 1997, pp. 267-274
INDIVIDUAL NUCLEI DIFFER IN THEIR SENSITIVITY TO THE CYTOPLASMIC INDUCERS OF DNA-SYNTHESIS - IMPLICATIONS FOR THE ORIGIN OF CELL-CYCLE VARIABILITY
Authors: HOLA M HOWARD M NAWAZ FN CASTLEDEN S BROOKS RF
Citation: M. Hola et al., INDIVIDUAL NUCLEI DIFFER IN THEIR SENSITIVITY TO THE CYTOPLASMIC INDUCERS OF DNA-SYNTHESIS - IMPLICATIONS FOR THE ORIGIN OF CELL-CYCLE VARIABILITY, Experimental cell research, 229(2), 1996, pp. 350-359
COMBINATION GENE THERAPIES FOR THE TREATMENT OF MALIGNANT-MELANOMA IN-VIVO
Authors: VILEA R CHONG H DIAZ RM HART I CASTLEDEN S TUSZYNSKI A
Citation: R. Vilea et al., COMBINATION GENE THERAPIES FOR THE TREATMENT OF MALIGNANT-MELANOMA IN-VIVO, European journal of cancer, 31A, 1995, pp. 37-37
IN-VIVO GENE-THERAPY OF METASTATIC MELANOMA USING THE HSVTK GENE BY COACTIVATION OL ANTITUMOR IMMUNITY
Authors: CASTLEDEN S TUSZYNSKI A CHONG H HART I VILE R
Citation: S. Castleden et al., IN-VIVO GENE-THERAPY OF METASTATIC MELANOMA USING THE HSVTK GENE BY COACTIVATION OL ANTITUMOR IMMUNITY, European journal of cancer, 31A, 1995, pp. 34-34
THE USE OF COMBINATION GENE THERAPIES FOR THE TREATMENT OF CANCER
Authors: CASTLEDEN S NELSON JA CHONG H HART I
Citation: S. Castleden et al., THE USE OF COMBINATION GENE THERAPIES FOR THE TREATMENT OF CANCER, Journal of cellular biochemistry, 1995, pp. 418-418
INITIATION OF DNA-SYNTHESIS BY NUCLEI FROM SCRAPE-RUPTURED QUIESCENT MAMMALIAN-CELLS IN HIGH-SPEED SUPERNATANTS OF XENOPUS EGG EXTRACTS
Authors: HOLA M CASTLEDEN S HOWARD M BROOKS RF
Citation: M. Hola et al., INITIATION OF DNA-SYNTHESIS BY NUCLEI FROM SCRAPE-RUPTURED QUIESCENT MAMMALIAN-CELLS IN HIGH-SPEED SUPERNATANTS OF XENOPUS EGG EXTRACTS, Journal of Cell Science, 107, 1994, pp. 3045-3053
SYSTEMIC GENE-THERAPY OF MURINE MELANOMA USING TISSUE-SPECIFIC EXPRESSION OF THE HSVTK GENE INVOLVES AN IMMUNE COMPONENT
Authors: VILE RG NELSON JA CASTLEDEN S CHONG H HART IR
Citation: Rg. Vile et al., SYSTEMIC GENE-THERAPY OF MURINE MELANOMA USING TISSUE-SPECIFIC EXPRESSION OF THE HSVTK GENE INVOLVES AN IMMUNE COMPONENT, Cancer research, 54(23), 1994, pp. 6228-6234
Risultati: 1-8 |